Company profile
KeyaMed NA Inc.
KeyaMed NA Inc. has 1 AI-enabled medical device on the FDA list. The first decision was on April 1, 2022 and the most recent on April 1, 2022 (DEEPVESSEL FFR). Its most common review panel is Cardiovascular (1 device).
1AI devices
2022First decision
2022Latest decision
1Specialties
Timeline
- DEEPVESSEL FFR · Cardiovascular · PJA